Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine
August 05 2019 - 9:30AM
InvestorsHub NewsWire
Canbiola Launches Dedicated Canbiola-Branded CBD Dispensing Machine
Initial 25 Units Will Target
Medical Offices
HICKSVILLE, NY -- August 5, 2019 --
InvestorsHub NewsWire -- Canbiola, Inc. (OTCQB:CANB)
(“Canbiola” or the “Company”), a developer, manufacturer, and
seller of a variety of Cannabidiol (Hemp) based products such as
oils, creams, moisturizers, chews, isolate, gel caps, and
concentrate announced today the launch of its own Canbiola-branded
CBD product dispensing machine. An initial order for the first 25
units has been placed with the installations expected to occur in
August and September.
The initial focus of this new direct-to-consumer
marketing strategy will be to place the product dispensing machines
in MRI locations, outpatient surgery centers, urgent care,
and physician offices. Each product dispensing machine will
dispense a variety of up to 10 Canbiola’s Branded CBD products and a
total of 150 units, including hemp oil drops, CBD salve and CBD
Cryo Gel. The product dispensing machines include a video screen
with an explanation of CBD, a doctor interview/tutorial on the
effects and benefits of CBD and certificate of analysis copies from
a third-party lab. Based on traffic and usage, the product
dispensing machines can easily be moved or have additional SKUs
added.
Canbiola Chief
Executive Officer Marco Alfonsi commented, “We are very excited
with the launch of our own dedicated Canbiola product dispensing
machines. Feedback from the medical community and specifically many
of the 30-60+ medical offices we are currently partnered with
suggested the direct-to-consumer machines due to demand,
convenience and ease-of-use will be a success. We are initially
rolling out the product dispensing machines to areas within the
medical community, but may include high traffic areas, such as
shopping malls in the future.”
About Canbiola,
Inc.
Canbiola, Inc. (OTCQB: CANB). is a Company
specializing in the manufacturing, formulating and sale of
Cannabidiol (Hemp-derived CBD) based products such as
drops/tinctures, oils, creams, moisturizers, chews, isolate gel
caps and concentrates. All Canbiola products are organic and
Non-GMO, formulated with the finest ingredients and manufacturing
standards. All products are certified for purity and accuracy by
third-party laboratory
verification.
Canbiola pursues its aggressive growth strategy
through the development of its proprietary line of products and
expanding its product offerings through strategic acquisitions in
the healthcare and CBD
Industries.
Canbiola’s marketing strategy incorporates the
creation and delivery of innovative new products through targeted
marketing channels. These marketing channels
include:
·
The Canbiola clinical line which is marketed and promoted through
healthcare practitioners.
·
Both the Pure Leaf Oil (consumer brand) and Seven Chakras (infused
product spa line) lines are sold through retail outlets both online
and brick and mortar.
Canbiola’s state-of-the-art manufacturing facility
in Lacey WA, Pure Health Products LLC (PHP) also offers private
label and white label solutions for companies looking to add
high-quality CBD products to their product offerings. Canbiola Inc.
is passionate about improving people's lives. We take pride in
providing pure products infused with organic and natural
ingredients. We want customers to know that they are buying
lab-tested, high-quality natural products at a great
price.
Additionally, Canbiola’s Radical Tactical LLC
subsidiary provides the marketplace with millennium targeted
product lines including such products as vapes, gums, and
kratom.
Duramed Inc. and DuramedNJ LLC, wholly-owned
subsidiaries of Canbiola further the mission of providing
innovative products designed to improve people’s lives and reducing
their dependence on opioid substance using its durable medical
device products. This product line includes an FDA cleared wearable
low-intensity ultrasound device delivering multi-hour treatment
intended to accelerate healing and improve function for
musculoskeletal injuries (muscle, tendon, ligament) and reducing
chronic pain (without opioid pain
medication).
With the creation of its newest wholly-owned
subsidiary, NY Hemp Depot LLC, Canbiola fulfills its mission to
become vertically integrated. By using its newly acquired NY
State Hemp Cultivation License, it allows the company to contract
with farmers in NY to grow specific strains of hemp for processing
to Canbiola’s exacting standards and specifications for isolate to
ship to its laboratory and production facility (PHP) in
WA.
Forward-Looking
Statements
Forward-looking statements and risks and
uncertainties discussed in this letter contain forward-looking
statements. The words "anticipate," "believe," "estimate," "may,"
"intend," "expect," and similar expressions identify such
forward-looking statements. Expected, actual results, performance,
or achievements could differ materially from those contemplated,
expressed, or implied by the forward-looking statements contained
herein. Forward-looking statements are subject to a number of risks
and uncertainties, including but not limited to, risks and
uncertainties associated with, among other things, the impact of
economic, competitive, and other factors affecting our operations,
markets, products, and performance. The matters discussed herein
should not be construed in any way, shape or manner of our future
financial condition or stock price.
Follow Canbiola on:
Twitter
@CanbiolaHealth
Instagram @canbiola.inc or @canbiola_cbd or
@canbiola_medical_cbd
Follow us on Twitter and Facebook
Investors and Media:
IR@canbiola.com
(516) 595-9544
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Aug 2024 to Sep 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Sep 2023 to Sep 2024